Socioeconomic status, race, and location can all have enormous impacts on the cancer outcome of a patient. When we think of a cancer diagnosis, we often think in stages or grades and forget that the day-to-day life of a patient has just as much of an impact on their long-term outcome.
Read more
Canopy, the first Intelligent Care Platform for oncology, today announced results from a seventeen-month, real-world study of their ePRO-based patient monitoring platform. The single-site study of 923 patients at Highlands Oncology Group demonstrates the Canopy platform can be effectively implemented at a large scale with a high level of long-term patient enrollment, engagement, and retention. The study also found that the vast majority of patient issues were effectively resolved by nurse specialists and physician intervention was infrequently required.
Read more
Canopy, the first Intelligent Care Platform for oncology, today announced they will be presenting their research on the patient impact of their ePRO-based patient monitoring platform at the 2022 American Society of Clinical Oncology (ASCO) Annual Meeting, to be held June 3-7.
Read more
Canopy, the Intelligent Care Platform (ICP) for oncology, today announced it has raised$13 million in funding led by GSR Ventures, with participation from Samsung Next, UpWest, and other industry leaders and executives, such as Geoff Calkins (former SVP Product, Flatiron Health), and Chris Mansi (CEO Of Viz.AI). Formerly known as Expain, Canopy is also launching out of stealth today to make its platform generally available to cancer treatment centers across the U.S.
Read more
Jan 01 2023
Nov 07 2022
Sep 06 2022
Mar 19 2022
Mar 18 2022
Mar 17 2022
Mar 17 2022
